POULTRY 
Coccidiosis Control in a Gel Droplet
A unique coccidiosis vaccine that perfectly balances safety and efficacy in a gel droplet
The Immucox Difference
Coccidiosis is a constant threat in poultry production, capable of damaging gut health, reducing performance, and significantly affecting financial results.
Protecting birds early and consistently is essential. IMMUCOX® provides a dependable vaccination solution that supports natural immunity and helps producers maintain strong flock performance across broilers, layers, breeders, and turkeys.
Backed by Ceva’s expertise in poultry vaccination and hatchery technology, IMMUCOX® delivers controlled exposure to key Eimeria species, aligning with the growing demand for sustainable, antibiotic‑free and “No Anticoccidial” systems. Its design ensures predictable protection and practical integration into modern hatchery workflows.
IMMUCOX® Designed to help healthy Chickens & Turkeys develop immunity against Coccidiosis
Availability & Application
Formulations Adapted to Each Production Type
IMMUCOX® is available in three targeted formulations, each matched to species‑specific Eimeria profiles:
- IMMUCOX® 3 – Broilers
- IMMUCOX® 5 – Layers & Breeders
- IMMUCOX® T – Turkeys
Presentation
A liquid suspension of live sporulated oocysts, supplied in multi‑dose vials (1,000–5,000 doses), designed for efficient hatchery use.
Immucox®3 is a live oral coccidiosis vaccine for Broilers, that contains sporulated oocysts of :
- Eimeria acervulina
- Eimeria maxima
- Eimeria tenella
A unique coccidiosis vaccine that perfectly balances the safety and efficacy needed for broilers that are raised without antibiotics and anticoccidial resistance management programs.
Immucox®5 is a Live oral coccidiosis vaccine for Breeders & Layers , that contains sporulated oocysts of :
- Eimeria acervulina
- Eimeria maxima
- Eimeria tenella
- Eimeria necatrix
- Eimeria brunetti
A unique coccidiosis vaccine that perfectly balances safety and efficacy, in a gel droplet to prevent economic losses caused by coccidiosis in long-living birds.
Immucox®T is a live oral coccidiosis vaccine for Turkeys, that contains sporulated oocysts of :
- Eimeria adenoides
- Eimeria meleagremitis
A unique coccidiosis vaccine that perfectly balances the safety and efficacy needed for Turkeys that are raised without antibiotics and anticoccidial resistance management programs.
Hatchery Gel‑Droplet Application
Applied via automated gel‑spray systems using CevaGel® to ensure:
- Even droplet distribution
- Easy ingestion
- Controlled, uniform vaccine intake
Fully compatible with modern hatchery automation for high‑throughput vaccination.
Dosage & Administration
Reconstituted in CevaGel® and applied at a controlled volume per chick box to guarantee uniform coverage and consistent immune stimulation.
Storage & Handling
- Store at +2°C to +8°C
- Do not freeze
- Maintain cold chain to preserve oocyst viability
Proper handling ensures the stability and performance of each dose.
1. Safety & Efficacy
IMMUCOX® is formulated to induce strong and fast protective immunity against coccidiosis.
The IMMUCOX® difference begins with its safety and efficacy.
IMMUCOX® uses carefully calibrated, fully sporulated Eimeria oocysts to promote early, natural immunity while minimizing intestinal impact. This balance supports bird welfare, uniformity, and expected performance.
- The ingestion of an optimum number of full-cycle oocysts efficiently induces fast development of a robust immune response.
- Its unique formulation allows safe vaccine cycling.
2. Consistency You Can Rely On
IMMUCOX® is formulated to ensure minimal variation in the oocyst viability and infectivity during its shelf life.
Vaccine’s consistency is achieved by its unique formulation and viability of oocysts at production.
With strict control of oocyst viability and concentration, IMMUCOX® delivers reliable results flock after flock. Producers benefit from predictable cycling, reduced variability, and stable performance in diverse production environments.
3. Optimal Vaccine Take
IMMUCOX® is applied with state-of-the-art equipment, Desvac Duo, and CevaGel technology.
Applied through CevaGel® gel‑droplet technology, IMMUCOX® ensures a more uniform oocyst distribution and easy ingestion for chicks. This method improves vaccine intake, reduces under‑ or over‑dosing, and supports uniform immunity from day one.
Contact us for more information
Contact usIMMUCOX® UNIQUE FEATURES & ADVANTAGES
The optimum oocyst number ensure:
Safety – Cause minimal intestinal damage and no detrimental effect on performance and uniformity.
Immucox® contains full-cycle Eimerias, which produce an optimum oocyst output increasing the opportunity for every bird in a flock to find and recycle vaccinal oocysts, stimulating rapid and robust immune response.
Shelf-life prevents variations in oocyst viability ensuring consistency in the safety and efficacy
Oocysts uniformly distributed in CevaGel (gel diluent).
- Uniform distribution of the vaccine in the chick box, maximize vaccine uptake.
- The rate of vaccine uptake can be measured at the hatchery.
Key Benefits Delivered by IMMUCOX®
Strong and Early Immunity
IMMUCOX® contains fully sporulated, live Eimeria oocysts designed to trigger a rapid and effective immune response. This controlled exposure encourages natural cycling of the parasite, enabling birds to develop sustained protection during the most critical phases of their development.
Balanced Safety and Efficacy
Each IMMUCOX® formulation delivers a carefully calibrated dose of oocysts to stimulate immunity without causing excessive intestinal damage. This balance ensures that birds maintain expected performance, growth curves, and flock uniformity throughout production.
Reliable Results and Consistency
The precision of oocyst viability and dosage ensures reproducible outcomes across different batches and production cycles. This consistency reduces field variability and supports predictable performance, a crucial factor for integrated operations and large‑scale hatcheries.
Uniform Vaccine Uptake Through CevaGel® Technology
IMMUCOX® is designed for administration via CevaGel®, which ensures even distribution of vaccine droplets and maximizes ingestion by chicks. This approach minimizes the risks of under‑ or over‑dosing, helping deliver uniform immunity across all vaccinated birds.
Economic Advantages
By reducing coccidiosis‑related losses, IMMUCOX® helps improve the economic efficiency of poultry operations. Benefits include:
- Lower mortality
- Reduced feed conversion losses
- Decreased growth depression
- Better overall return on investment for both broilers and long‑lived birds
IMMUCOX® - Key benefits
Contact Us for more information
Contact usCoccidiosis
Coccidiosis is a disease caused by Eimeria parasites commonly observed in mammals and birds’ intestinal tract. In chickens and turkeys, infection by this parasite is costly to both the producer (higher feed conversion ratios, depressed growth, and increased flock mortality) and the industry, causing billions of dollars in losses worldwide.
